ArticleFrontiers in oncology2025
A CT-based interpretable machine learning model for preoperative prediction of pancreatic neuroendocrine tumor aggressiveness.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to develop and validate an interpretable machine learning (ML) model based on structured preoperative CT features for non-invasive prediction of pancreatic neuroendocrine Tumors (PNETs) aggressiveness. Methods: This retrospective study included 112 patients with PNETs who underwent contrast-enhanced abdominal CT. Patients were randomly assigned to training and validation cohorts. Clinical data and CT features were analysed using the Least Absolute Shrinkage and Selection Operator method and multivariate logistic regression to identify independent risk factors. Multiple ML models were evaluated to determine the optimal classifier. Model performance was assessed using receiver operating characteristic and calibration curves, and decision curve analysis. Shapley Additive Explanations (SHAP) quantified feature importance for interpretable risk prediction. Results: A total of 112 patients were evaluated, including 80(mean age± standard deviation, 47 ± 13 years; 36 males)) in the training set and 32 (48 ± 15 years; 12 males) in the validation set. Tumour shape, necrotic changes, arterial relative enhancement ratio, and enhancement pattern independently predicted PNETs aggressiveness. The logistic regression model demonstrated excellent discrimination, achieving an area under the curve of 0.952 (95% CI: 0.952 (0.909-0.994) in the training cohort and 0.972 (95% CI 0.927-1.000) in the validation cohort. SHAP summary and force plots facilitated global and local model interpretation. Conclusion: The Interpretable ML model based on CT features could serve as a preoperative, noninvasive, and precise evaluation tool to differentiate aggressive and non-aggressive PNETs, facilitating personalized clinical management and potentially improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.